Traditional Chinese medicine (TCM) culture is an important part of China culture and a vivid imprint of China's 5,000-year-old traditional culture. As the distribution center of Chinese medicine and the birthplace of Chinese medicine culture, there are four places with the highest recognition in history, namely "Bozhou, Anhui, Anguo, Hebei, Zhangshu, Jiangxi and Yuzhou, Henan". However, since the beginning of 2 1 century, with the acceleration of the docking of production and demand, the market pattern of Chinese herbal medicines has also undergone major changes.

1996, state administration of traditional chinese medicine, Ministry of Health, State Administration for Industry and Commerce and other departments recognized 17 the specialized market of Chinese herbal medicines, namely, Bozhou, Anhui; Yuzhou, Henan; Chengdu lotus pond; Hebei anguo; Jiangxi camphor tree; Guangzhou Qingping; Shunwangcheng, Juancheng County, Shandong Province; Chongqing Jiefang Road; Three trees in Harbin; Lanzhou yellow river medicine market.

From the layout, we will find that the main consideration at that time was historical inheritance, but not the richness of surrounding resources, so the layout was unreasonable. Such as Gansu Longxi, Henan Wuzhi, Zhejiang Pan 'an, Shandong Pingyi and other large-scale Chinese herbal medicine production markets are obviously too far away from the trading market, and the degree of resource integration is insufficient.

First, the number of employees.

According to the statistical analysis of big data platform of Chinese medicine industry, Bozhou is still the largest market in 8984, followed by Anguo, Chengdu, Kunming and Guangzhou. Huabanqiao in Changsha, the Yellow River in Lanzhou, Jiefang Road in Chongqing and Sanshu in Harbin have seen their markets shrink sharply because they are far away from their producing areas. In other words, according to the number of employees, Bozhou, Anguo, Chengdu Lotus Pond and Kunming Chrysanthemum Garden rank in the top four, making them the new four drug capitals.

Second, from the perspective of market circulation scale.

In terms of transaction scale, Bozhou, Anhui, Qingping, Anguo, Hebei, and Yulin, Guangxi rank among the top four by calculating the annual traffic volume and transaction volume of networked vehicles. That is to say, from the perspective of transaction volume, Bozhou, Anhui, Qingping, Anguo, Hebei and Yulin, Guangxi are the four major new drug capitals.

Third, from the perspective of transaction amount.

Thanks to the blessing of precious herbs and spices, many wholesale markets such as Ruyifang, Shanhai Market, Huang Qi Market and Chinese Medicine Port have been formed around Qingping, and the transaction volume is far ahead. Yulin also has a leading trading quota because of its wide variety of spices and the support of imported medicinal materials from Southeast Asia. On the contrary, it is Bozhou City. Due to the lack of precious medicinal materials, a large number of medicinal materials are mainly low-priced varieties, and the trading amount is only slightly higher than that in Chengdu Lotus Pond market.

Chengdu is the largest cordyceps sinensis trading market in China, and Puning is the largest American ginseng processing trading market in China, with a trading share far ahead of Anguo market. Therefore, according to the transaction volume, these four new drugs should be Qingping in Guangzhou, Yulin in Guangxi, Bozhou in Anhui and Lotus Pond in Chengdu.

Through the analysis of the above three aspects and the comprehensive evaluation of market brand influence, the four major new drugs in China should be Bozhou, Anhui, Qingping, Yulin, Guangxi and Anguo, Hebei.